Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ECTE > SEC Filings for ECTE > Form 8-K on 23-May-2013All Recent SEC Filings

Show all filings for ECHO THERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ECHO THERAPEUTICS, INC.


23-May-2013

Submission of Matters to a Vote of Security Holders, Financial Statements


Item 5.07. Submission of Matters to a Vote of Security Holders

At the 2013 Annual Meeting of Stockholders (the "Annual Meeting") of Echo Therapeutics, Inc. (the "Company") held on May 22, 2013, the following matters were acted upon by the Company's stockholders:

1. The election of Vincent D. Enright, a Class II director, to the Company's Board of Directors for a term of three years and the election of Robert F. Doman, a Class III director, to the Company's Board of Directors for a term of one year;

2. The approval of an amendment to the Company's Certificate of Incorporation, as amended, to effect a reverse stock split by a ratio of not less than 1-for-2 and not more than 1-for-10 at any time prior to December 31, 2013, with the exact ratio to be set within this range by the Company's Board of Directors in its sole discretion;

3. The approval of an amendment to the Company's 2008 Equity Incentive Plan to fix the aggregate number of shares of common stock subject to the 2008 Plan at 10,000,000 shares subject to the approval of the reverse stock split and after giving effect to the reverse stock split;

4. The approval of an amendment to the Company's 2008 Equity Incentive Plan to fix the limitation on awards of stock options during any twelve-month period to any one participant at 425,000 shares, subject to the approval of the reverse stock split and after giving effect to the reverse stock split;

5. The ratification of the appointment of Wolf & Company, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2013.

The results of voting on each of the matters presented to stockholders at the Annual Meeting are set forth below:

1. Election of Vincent D. Enright, a Class II director, to the Company's Board of Directors for a term of three years and the election of Robert F. Doman, a Class III director, to the Company's Board of Directors for a term of one year:

                                                                                    BROKER
                         FOR           AGAINST / WITHHELD       ABSTENTIONS       NON-VOTES
Vincent D. Enright     22,889,879                2,513,691                 -       19,758,835
Robert F. Doman        22,885,577                2,517,993                 -       19,758,835

2. Approval of an amendment to the Company's Certificate of Incorporation, as amended, to effect a reverse stock split by a ratio of not less than 1-for-2 and not more than 1-for-10 at any time prior to December 31, 2013, with the exact ratio to be set within this range by the Company's Board of Directors in its sole discretion:

                                                               BROKER
    FOR           AGAINST / WITHHELD       ABSTENTIONS       NON-VOTES
  22,811,468                2,197,289           394,813       19,758,835


3. Approval of an amendment to the Company's 2008 Equity Incentive Plan to fix the aggregate number of shares of common stock subject to the 2008 Plan at 10,000,000 shares subject to the approval of the reverse stock split and after giving effect to the reverse stock split:

                                                              BROKER
    FOR           AGAINST / WITHHELD      ABSTENTIONS       NON-VOTES
  18,464,850                5,064,006        1,874,714       19,758,835

4. Approval of an amendment to the Company's 2008 Equity Incentive Plan to fix the limitation on awards of stock options during any twelve-month period to any one participant at 425,000 shares, subject to the approval of the reverse stock split and after giving effect to the reverse stock split:

                                                              BROKER
    FOR           AGAINST / WITHHELD      ABSTENTIONS       NON-VOTES
  18,574,257                4,980,114        1,849,189       19,758,835

5. Ratification of the appointment of Wolf & Company, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2013:

                                                              BROKER
    FOR           AGAINST / WITHHELD       ABSTENTIONS       NON-VOTES
  43,309,683                1,197,673           655,049               -



Item 9.01. Financial Statements and Exhibits.

The Exhibits listed in the Exhibit Index immediately preceding such Exhibits are filed with or incorporated by reference in this report.


  Add ECTE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ECTE - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.